Nebraska Administrative Code
Topic - HEALTH AND HUMAN SERVICES SYSTEM
Title 181 - SPECIAL HEALTH PROGRAMS
Chapter 8 - NONSURGICAL PHARMACEUTICAL GENDER ALTERING TREATMENTS
Section 181-8-015 - CROSS-SEX HORMONES WAITING PERIOD

Current through September 17, 2024

A minimum waiting period of seven calendar days is required between the time the prescribing practitioner obtains informed patient consent and the time the cross-sex hormones are prescribed, administered, or delivered to a patient who has not reached the age of majority.

Disclaimer: These regulations may not be the most recent version. Nebraska may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.